1. Home
  2. MGPI vs LBRX Comparison

MGPI vs LBRX Comparison

Compare MGPI & LBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MGP Ingredients Inc.

MGPI

MGP Ingredients Inc.

HOLD

Current Price

$24.25

Market Cap

516.4M

ML Signal

HOLD

LBRX

LB Pharmaceuticals Inc

N/A

Current Price

$21.49

Market Cap

544.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MGPI
LBRX
Founded
1941
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
516.4M
544.7M
IPO Year
1988
2025

Fundamental Metrics

Financial Performance
Metric
MGPI
LBRX
Price
$24.25
$21.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$40.00
$49.00
AVG Volume (30 Days)
536.3K
488.0K
Earning Date
10-29-2025
02-15-2026
Dividend Yield
1.98%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$578,855,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.67
$13.36
52 Week High
$40.64
$23.15

Technical Indicators

Market Signals
Indicator
MGPI
LBRX
Relative Strength Index (RSI) 46.73 N/A
Support Level $23.46 N/A
Resistance Level $24.32 N/A
Average True Range (ATR) 0.85 0.00
MACD -0.11 0.00
Stochastic Oscillator 22.43 0.00

Price Performance

Historical Comparison
MGPI
LBRX

About MGPI MGP Ingredients Inc.

MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives its revenue from the Distillery Solutions segment.

About LBRX LB Pharmaceuticals Inc

LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. It is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which the company believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a new chemical entity and a methylated derivative of amisulpride, a second-generation antipsychotic drug approved in over 50 countries.

Share on Social Networks: